Add this event to your calendar05/24/18 – 05/26/1805/26/18Deutsche Gesellschaft für Pathologie (DGP) 2018
Join our Symposium on Saturday 26th May to hear from leading
scientists using NGS for comprehensive tumor profiling, the detection
of Microsatellite instability regions and Tumour Mutational Burden.
Visit Illumina at stand 42 to find out how we can assist your
laboratory with the molecular assessment of tumor samples.
Add this event to your calendar05/30/1805/30/18Illumina Next-Generation Sequencing (NGS) Seminar at JCVI
Join us for a seminar to learn how Illumina®technology can
help you uncover the answers to drive your research forward.
During this event, Illumina experts will present an overview of
next-generation sequencing (NGS), highlight recent application and
platform updates, and discuss the basic concepts and key advantages
over traditional technologies.
Add this event to your calendar05/31/1805/31/18Illumina User Group Meeting - Toronto
Join us for the Illumina User Group Meeting in Toronto on Thursday,
May 31, and learn about the progress being made using Illumina
next-generation sequencing (NGS) and technology. You’ll hear from
researchers like you, about the discoveries they have made with
genomic technology and how they continue to move the needle in our
joint quest to unlock the power of the human genome. We’ll also
provide updates on all things Illumina. NGS is fast becoming the
standard in helping to advance these disciplines and we look forward
to sharing this exciting research with you.
Group Meetings provide an invaluable forum to learn how the latest
technology and methods can accelerate your discoveries.
Who Should Attend:
Illumina User Group Meetings are exclusively for those who own,
use, or have their data generated on Illumina instrumentation.
The presentations will cover a broad range of applications and are
designed for new or experienced users in the areas of optimization of
the sequencing workflow or bioinformatics.
Add this event to your calendar06/07/1806/07/18Next-Generation Sequencing for Immuno-Oncology Research Seminar
Recent advances in our understanding of how the immune system
interacts with and fights cancer have revolutionized cancer research
The power of genomics in Immuno-Oncology
is just starting to be comprehended and applied to this dynamic space.
Immune cell repertoire sequencing, RNA-Seq and expression analysis of
the tumor microenvironment, and the detection and prediction of immune
stimulatory neoantigens are all examples of how genomics can help to
answer many of the unknown questions that still exist.
Please join us for a unique opportunity where we will bring together
speakers to discuss how they are using next-generation sequencing in
this exciting space. Whether you are interested in advancing your
research, bringing game-changing therapies to market, or partnering to
maximize the effectiveness of translational studies, this event aims
to provide the research community with insights and ideas to further
our understanding of how the immune system can be optimized to fight cancer.
Mark Pegram, MD, Director of the Breast Oncology Program,
Associate Director of Clinical Research, Associate Dean for Clinical
Research Quality, Stanford Cancer Institute
Pharmaceutical Business Specialist, Illumina, Inc.
Eimerman, PhD, Sr Segment Marketing Manager, Illumina, Inc.
Drew Kebbel, Sequencing & Data Analysis Specialist, ,
Brian Fritz, PhD, Strategic Marketing , 10X
Add this event to your calendar06/16/18 – 06/19/1806/19/18European Society of Human Genetics (ESHG) 2018
Visit us at stand 540 to learn about our latest advancements in
genomic solutions. From whole-genome sequencing to single cell
sequencing, we have solutions across the genomic spectrum. Attend our
presentations, product demonstrations, and social event to find out more.
Add this event to your calendar06/19/1806/19/18Illumina User Group Meeting - Halifax
Join us for the Illumina User Group Meeting in Halifax on Tuesday,
June 19, and learn about the progress being made using Illumina
next-generation sequencing (NGS) and technology. You’ll hear from
researchers like you about the discoveries they have made with genomic
technology and how they continue to move the needle in our joint quest
to unlock the power of the genome. We’ll also provide updates on all
things Illumina. NGS is fast becoming the standard in helping to
advance these disciplines and we look forward to sharing this exciting
research with you.
Illumina User Group Meetings provide an invaluable forum to learn
how the latest technology and methods can accelerate your discoveries.
Who Should Attend: Illumina User Group Meetings
are exclusively for those who own, use, or have their data generated
on Illumina instrumentation. The presentations will cover a broad
range of applications and are designed for new or experienced users in
the areas of optimization of the sequencing workflow or bioinformatics.
Add this event to your calendar06/30/18 On demand06/30/18Introductory Methylation study: towards new pathways in type 2 diabetes pathophysiology
Watch this on demand webinar by Dr Amelie Bonnefond - European
Institute of Study of Diabetes (EGID), CNRS in France, to hear how
studying the methylome and transcriptome can open up new,
potential therapeutic avenues by revealing new pathways involved
in common complex diseases like type 2 diabetes.
Add this event to your calendar06/30/18 On demand06/30/18An Integrative genomic approach to precision medicine of rare disease
Watch this On Demand webinar to learn more about Dr. Palau’s
transition from genetic testing to genome testing and how a
multi-disciplinary team approach can help improve the
understanding of rare diseases.
Add this event to your calendar06/30/18 – 07/03/1807/03/1825th Biennial Congress of the European Association for Cancer Research (EACR 25) 2018
Visit us at stand 31 & 32 to learn about our latest advancements
in genomic solutions for Cancer Research. Attend our workshop on
Monday 02 July in room G105 to learn how: “How can next-generation
sequencing (NGS) can empower your next cancer research
The session will feature two
presentations: one discussing how single cell genomics is transforming
our understanding of various immune-related pathologies, such as
cancer and one about how RNA-Seq can provide insights into
quantification of immune contexture within human tumors.
Add this event to your calendar07/09/18 – 07/11/1807/11/1822nd International Conference on Prenatal Diagnosis and Therapy (ISPD) 2018
Visit Illumina on booth #5 at ISPD 2018 in Antwerp.
Illumina is the leading technology provider for noninvasive prenatal
testing (NIPT), enabling health care professionals and expectant
parents to be informed about their pregnancy. Illumina is dedicated to
improving health through genomics.
Add this event to your calendar01/30/18 8 AM and 5 PM01/30/18Introducing the iSeq™ 100 Sequencing System—our latest solution for fast and efficient low-throughput sequencing for virtually any lab
Explore our smallest and most cost-effective sequencer ever. Join
Bellal Moghis and Gary Schroth as they introduce our newest
system—iSeq 100. They’ll walk through installation and also review
applications and methods. Find out how you can make the most of your
new lab partner.
Add this event to your calendar01/24/18 10 AM (PT)01/24/18CosmosID Metagenomics for Public Health, Food/Water Safety, and Epidemiology
With the dramatically increasing amount of sequence data generation
and the significant reduction of sequencing costs, rapid, easy, and
accurate data analytics becomes the critical bottleneck in adopting
next-generation sequencing (NGS) in the public health sector. To this
end, CosmosID has developed a cloud-based microbial genomics platform
featuring with world’s largest curated genome databases and scaling
computational power to keep pace with the ever-increasing amount of
data generation. The platform brings together the most comprehensive
and ultrafast “sequence to answer” workflow for easy, accurate, and
highly resolved profiling of cross-disciplinary microbiome data. In
this webinar, various aspects of the platform will be presented with
reference to recent studies on water and wastewater treatment, food
safety, molecular epidemiology, and multi-kingdom microbiome profiling
and characterization. Key technologies that will be showcased include
strain-level metagenomics, metatranscriptomics, metagenomic assembly,
and molecular sub-typing.
Add this event to your calendar01/23/18 8 AM and 5 PM01/23/18AmpliSeq™ for Illumina®—fast, simple, robust targeted library prep chemistry for Illumina sequencing systems
See what happens when a leading library prep is optimized to run on
next-generation sequencing (NGS) systems from Illumina. Join Mitu
Chaudhary and Claire White as they present data to demonstrate the
robust performance of AmpliSeq for Illumina from a wide variety of
Add this event to your calendar12/13/17 10 AM (PT)12/13/17High-volume sequence analysis with BaseSpace Sequence Hub and Edico Genome DRAGEN apps
The latest sequencing technologies enable unprecedented throughput
and redefine limits for many labs. To adapt, these labs must redefine
how they work – by automating tasks to reduce touchpoints and by
simplifying workflows with integration and robust analysis tools. In
this webinar, we describe BaseSpace™ Sequence Hub and how the newest
features support high throughput, high-volume sequencing. We
demonstrate how customers can progress from flowcell loading to
variant analysis with zero touchpoints by using the Whole Genome
Sequencing or Edico Genome DRAGEN apps. Additionally, we describe how
the integration with BaseSpace™ Variant Interpreter enables users to
interpret and generate reports of identified variants.
Add this event to your calendar12/07/17 10 AM (PT)12/07/17Enabling efficient Discovery and Clinical Research in drug response: Application of a targeted Next-Generation Sequencing Assay for Pharmacogenetics
Pharmacogenetic (PGx) testing enables researchers to understand a
person’s genetic propensity for a therapeutic response or an adverse
reaction to particular medications. Recently the NIH’s Precision
Medicine Initiative has begun a nationwide effort to individualize a
subject’s treatment program, while the FDA has already included PGx
information in over one hundred drug labels. Serious drug reaction
events are likely to become more prevalent as more drugs become
available and the number of pharmaceuticals each person is taking
increases. To understand the occurrence of these events, sequencing
genomic regions associated with metabolism of a wide-spectrum of drug
classes can help inform clinical researchers, and better characterize
the frequency of known and novel haplotypes within validated genes
involved in drug metabolism pathways.
presentation, we will describe a method and workflow for targeted
pharmacogenetic gene sequencing using Kailos’ TargetRichTM PGxComplete assay.
Add this event to your calendar12/06/17 10 AM (PT)12/06/17The Yin and Yang of NGS HLA typing
The Webinar Series will feature HLA laboratory directors presenting
case studies from samples prepared with TruSight™ HLA, sequenced with
Illumina next-generation sequencing (NGS) MiSeq or MiniSeq systems,
and analyzed using TruSight HLA Assign software. Presentations will be
followed by an interactive question and answer session.
The webinar will offer participants:
Advanced sequencing data analysis and data interpretation in
Continuing education in current and
relevant topics in Histocompatibility and Immunogenetics
opportunity to share best practices and troubleshooting tips in data
analysis and HLA typing by NGS